P/Q-type voltage-gated calcium channel antibodies in paraneoplastic disorders of the central nervous system

Muscle and Nerve

Volumn 22, Issue 1, 1999, Pages 119-122

  Voltz, Raymond ^a   Carpentier, Antoine F ^a   Rosenfeld, Myrna R ^a,b   Posner, Jerome B ^a,b   Dalmau, Josep ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Anti Hu; P Q type voltage gated calcium channel antibodies; Paraneoplastic neurological disorders; Paraneoplastlc cerebellar degeneration

Indexed keywords

CALCIUM CHANNEL; TUMOR MARKER; VOLTAGE GATED CHANNEL FORMING PROTEIN;

ANTIBODY BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; CENTRAL NERVOUS SYSTEM; CEREBELLUM DEGENERATION; CONTROLLED STUDY; CORRELATION FUNCTION; EATON LAMBERT SYNDROME; HUMAN; HUMAN CELL; IMMUNOASSAY; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; RADIOIMMUNOPRECIPITATION;

AUTOANTIBODIES; CALCIUM CHANNELS; CALCIUM CHANNELS, N-TYPE; CARCINOMA, SMALL CELL; CENTRAL NERVOUS SYSTEM DISEASES; CEREBELLAR DISEASES; ENCEPHALOMYELITIS; FEMALE; HUMANS; LAMBERT-EATON MYASTHENIC SYNDROME; MYASTHENIA GRAVIS; NEOPLASMS; NEURODEGENERATIVE DISEASES; PARANEOPLASTIC SYNDROMES; RADIOIMMUNOASSAY;

EID: 0032889460     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(199901)22:1<119::AID-MUS19>3.0.CO;2-5     Document Type: Article

References (20)

1. Anderson HJ, Churchill-Davidson HC, Richardson AT. Bronchial neoplasm with myasthenia: prolonged apnoea after administration of succinylcholine. Lancet 1953;ii:1291-1293.
2. Bain PG, Motomura M, Newsom-Davis J, Misbah SA, Chapel HM, Lee ML, Vincent A, Lang B. Effects of intravenous immunoglobulin on muscle weakness and calcium-channel autoantibodies in the Lambert-Eaton myasthenic syndrome. Neurology 1996;47:678-683.
3. Birnbaumer L, Campbell KP, Catterall WA, Harpold MM, Hofman F, Horne WA, Mori Y, Schwartz A, Snutch TP, Tanabe T, Tsien RW. The naming of voltage-gated calcium channels. Neuron 1994;13:505-506.
4. Blumenfeld AM, Recht LD, Chad DA, DeGirolami U, Griffin T, Jaeckle KA. Coexistence of Lambert-Eaton myasthenic syndrome and subacute cerebellar degeneration: differential effects of treatment. Neurology 1991;41:1682-1685.
5. Clouston PD, Saper CB, Arbizu T, Johnston I, Lang B, Newsom-Davis J, Posner JB. Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology 1992;42:1944-1950.
6. Eaton LM, Lambert EH. Electromyography and electric stimulation of nerves in disease of motor unit - observations on myasthenic syndrome associated with malignant tumors. JAMA 1957;163:1117-1124.
7. Graus F, Dalmau J, Valldeoriola F, Ferrer I, Reñé R, Marin C, Vecht CJ, Arbizu T, Targa C, Moll JWB. Immunological characterization of a neuronal antibody (anti-Tr) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease. J Neuroimmunol 1997;74:55-61.
8. Kim YI, Neher E. IgG from patients with Lambert-Eaton syndrome blocks voltage-dependent calcium channels. Science 1988;239:405-408.
9. Lang B, Newsom-Davis J, Wray D, Vincent A, Murray N. Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet 1981;2:224-226.
10. Lennon VA, Kryzer TJ, Griesmann GE, O'Suilleabhain PE, Windebank AJ, Woppmann A, Miljanich GP, Lambert EH. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995;332: 1467-1474.
11. Mason WP, Graus F, Lang B, Honnorat J, Delattre J-Y, Vallderiola F, Antoine C, Rosenblum MK, Rosenfeld MR, Newson-Davis J, Posner JB, Dalmau J. Small-cell lung cancer, paraneoplastic cerebeliar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 1997;120:1279-1300.
12. Meriney SD, Hulsizer SC, Lennon VA, Grinnell AD. Lambert-Eaton myasthenic syndrome immunoglobulins react with multiple types of calcium channels in small-cell lung cancer. Ann Neurol 1996;40:739-749.
13. Motomura M, Johnston I, Lang B, Vincent A, Newsom-Davis J. An improved diagnostic assay for Lambert-Eaton syndrome. J Neurol Neurosurg Psychiatry 1995;58:85-87.
14. Motomura M, Lang B, Johnston I, Palace J, Vincent A, Newsom-Davis J. Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. J Neurol Sci 1997;147:35-42.
15. Oguro-Okano M, Griesmann GE, Wieben ED, Slajmaker SJ, Snutch TP, Lennon VA. Molecular diversity of neuronal-type calcium channels identified in small cell lung carcinoma. Mayo Clin Proc 1992;67:1150-1159.
16. Posner JB. Neurologic Complications of Cancer. Philadelphia: FA Davis Company; 1995.
17. Tanaka K, Motomura M, Nakao Y, Tanaka M, Tsuji S. Absence of anti-P/Q calcium channel antibody in the sera of patients with anti-Yo-positive paraneoplastic cerebellar degeneration. Neurology 1997;49:895-896.
18. Uchitel OD, Protti DA, Sanchez V, Cherskey BD, Sugumori M, Llinas R. P-type voltage-dependent calcium channel mediates presynaptic calcium influx and transmitter release in mammalian synapses. Proc Natl Acad Sci USA 1992;89:3330-3333.
19. Voltz R, Hohlfeld R. The use of intravenous immunoglobulin in the treatment of neuromuscular disorders. Curr Opin Neurol 1996;9:360-366.
20. Voltz RD, Graus F, Posner JB, Dalmau J. Paraneoplastic encephalomyelitis: an update of the effects of the anti-Hu immune response on the nervous system and tumor. J Neurol Neurosurg Psychiatry 1997;63:133-136.